The Down Under medical community is abuzz with the introduction of retatrutide, a innovative dual GIP and GLP-1 receptor agonist showing significant results in scientific trials for managing obesity. https://getsocialpr.com/story23615415/the-new-retatrutide-australia-a-emerging-solution-for-obesity-treatment